TUBULOINTERSTITIAL NEPHRITIS

This adverse event was reported 14048 times

These drugs are most commonly taken by patients reporting TUBULOINTERSTITIAL NEPHRITIS:

# Drug Count
0 OMEPRAZOLE MAGNESIUM 4803
1 ESOMEPRAZOLE MAGNESIUM 3900
2 LANSOPRAZOLE 3891
3 ESOMEPRAZOLE SODIUM 3625
4 PANTOPRAZOLE SODIUM 2892
5 DEXLANSOPRAZOLE 2171
6 OMEPRAZOLE 1962
7 FUROSEMIDE 1165
8 IBUPROFEN 1148
9 PANTOPRAZOLE 1127
See all common drugs associated with TUBULOINTERSTITIAL NEPHRITIS

TUBULOINTERSTITIAL NEPHRITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FERRIC SULFATE 10 0.1562
1 SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC 7 0.1129
2 ENEMA 7 0.0693
3 DEXLANSOPRAZOLE 2171 0.0604
4 COPANLISIB 18 0.0545
5 NAFCILLIN SODIUM 40 0.0501
6 RABEPRAZOLE SODIUM 1104 0.0466
7 NAPROXEN AND ESOMEPRAZOLE MAGNESIUM 317 0.0451
8 OMEPRAZOLE AND SODIUM BICARBONATE 125 0.0436
9 ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE 62 0.0430
See all drugs enriched for association with TUBULOINTERSTITIAL NEPHRITIS

TUBULOINTERSTITIAL NEPHRITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bismuth [EPC] 113 0.0253
1 Tubulin Inhibiting Agent [EPC] 5 0.0212
2 Interleukin-2 Receptor Blocking Antibody [EPC] 167 0.0205
3 Glycopeptide Antibacterial [EPC] 546 0.0119
4 Proton Pump Inhibitor [EPC] 5274 0.0118
5 Non-narcotic Antitussive [EPC] 127 0.0118
6 Anti-coagulant [EPC] 62 0.0112
7 Monobactam Antibacterial [EPC] 22 0.0109
8 Cephalosporin Antibacterial [EPC] 69 0.0108
9 Quinolone Antimicrobial [EPC] 978 0.0095
See all drug classes enriched for association with TUBULOINTERSTITIAL NEPHRITIS